Tilray Inc (NASDAQ:TLRY - Get Free Report) was down 4.9% during trading on Monday . The stock traded as low as $0.61 and last traded at $0.63. Approximately 6,884,910 shares were traded during trading, a decline of 77% from the average daily volume of 30,420,058 shares. The stock had previously closed at $0.66.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group upped their target price on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a report on Monday, January 13th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $2.70.
Check Out Our Latest Analysis on TLRY
Tilray Stock Down 1.7 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The company has a 50-day moving average price of $0.83 and a 200 day moving average price of $1.25. The firm has a market capitalization of $602.91 million, a PE ratio of -2.14 and a beta of 2.13.
Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.07). The business had revenue of $210.90 million during the quarter, compared to analysts' expectations of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. Tilray's revenue was up 8.7% on a year-over-year basis. Analysts forecast that Tilray Inc will post -0.2 earnings per share for the current year.
Institutional Trading of Tilray
Institutional investors and hedge funds have recently bought and sold shares of the stock. Lido Advisors LLC bought a new position in shares of Tilray during the 4th quarter valued at about $28,000. Verdence Capital Advisors LLC bought a new stake in shares of Tilray during the 4th quarter worth approximately $29,000. Dudley Capital Management LLC purchased a new position in Tilray during the 4th quarter valued at $29,000. Ameritas Advisory Services LLC bought a new position in Tilray in the 4th quarter valued at $32,000. Finally, Newman Dignan & Sheerar Inc. lifted its position in shares of Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock worth $35,000 after purchasing an additional 10,000 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Stories
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
